Malnutrition
Nutrition is fundamental for growth and neurologic development during childhood. However, malnutrition and growth impairment are common worldwide in infants and children with congenital heart disease (CHD). Growth failure is often multifactorial and may be attributable to inadequate energy intake, disordered oral feeding, increased metabolic demands, and disturbances in gastrointestinal (GI) function contributing to malabsorption. Associated genetic syndromes and chromosomal abnormalities may also lead to altered growth velocity. The combination of acute and chronic disease and pediatric malnutrition can have further detrimental effects on cognitive development, surgical outcomes, and disease-related morbidity and mortality.
Neonates with CHD are more vulnerable to nutrition deficits than at any other time during childhood, particularly preterm neonates or infants with intrauterine growth restriction. The risk of malnutrition is related to reduced nutrient stores at birth, immature absorption and utilization of nutrients, organ immaturity, delayed advancement of parenteral and enteral feeds, and dependence on health care providers to accurately identify and effectively provide optimal nutrition during a period of rapid growth and development. Nutrition requirements for infants and children with cardiac defects changes frequently throughout infancy through adulthood and will vary significantly depending on disease severity, cardiorespiratory status, surgical status (e.g., prior to or after surgery), and recovery status (e.g., acutely ill, chronically ill, early recovery, and recovered). The risk for growth failure depends on the particular lesion and its severity ( Table 86.1 ). Ongoing nutrition surveillance, screening, evaluation, and reevaluation throughout the stages of growth are necessary to improve early detection and intervention of nutrition deficits.
High Risk Prior to and After Surgical Management | High Risk Prior to Surgical Management; Improved by Surgery | Low Risk Prior to and After Surgical Management |
---|---|---|
Functionally univentricular heart (including hypoplastic left heart syndrome, pulmonary atresia, tricuspid atresia, isomerism and more; see Chapter 68 , Chapter 69 , Chapter 70 , Chapter 71 , Chapter 72 , Chapter 73 ) | Large ventricular septal defect (see Chapter 32 ) | Atrial septal defect (see Chapter 29 ) |
Atrioventricular septal defect with large ventricular component (see Chapter 31 ) | Tetralogy of Fallot (see Chapter 35 ) | |
Common arterial trunk (see Chapter 40 ) | Transposition of the great arteries (see Chapter 37 ) | |
Large patent arterial duct (see Chapter 41 ) | Totally anomalous pulmonary venous return (see Chapter 28 ) | |
Pulmonary artery hypertension (which is not amenable to surgery other than lung transplantation, see Chapter 75 ) | Aortic valve disease and left ventricular outflow tract obstruction (see Chapter 44 ) | |
Anomalous left coronary artery from the pulmonary artery (see Chapter 46 ) | Pulmonary stenosis (see Chapter 42 ) | |
Coarctation of the aorta and interruption of the aortic arch (see Chapter 45 ) |
However, it is important to also consider that infants, children, and adolescents with CHD may not be immune to risk of overweight and obesity. These children may have more sedentary lifestyles from restricted physical activity given perceived strain on the heart. Families may also continue a high-calorie diet that was previously encouraged during the period of time prior to surgery or resolution of heart failure.
Definition of Malnutrition
In 2014 the Academy of Nutrition and Dietetics and the American Society of Parenteral and Enteral Nutrition published a consensus statement defining pediatric malnutrition as, “an imbalance between nutrient requirement and intake, resulting in cumulative deficits of energy, protein or micronutrients that may negatively affect growth, development and other relevant outcomes” ( Table 86.2 ). Prior to this consensus statement, the prevalence of malnourished children in the United States was documented between 6% and 51%. Factors contributing to this large variance in documented malnutrition included a lack of uniform definitions, lack of heterogeneous nutrition screening practices, and failure to prioritize nutrition as part of patient care.
Severe protein-calorie malnutrition ICD-10 (E43) | Single data point indications:
|
Multiple data point indicators:
| |
Moderate malnutrition ICD-10 (E44.0) | Single data point indications:
|
Multiple data point indicators:
| |
Mild malnutrition ICD-10 (E44.1) | Single data point indications:
|
Multiple data point indicators:
|
Severe protein-calorie malnutrition ICD-10 (E 43) | Primary indicator requiring 1 indicator:
|
Primary indicator requiring two or more indicators:
| |
Moderate malnutrition ICD-10 (E44.0) | Primary indicator requiring one indicator:
|
Primary indicator requiring two or more indicators:
| |
Mild malnutrition ICD-10 (E44.1) | Primary indicator requiring one indicator:
|
Primary indicator requiring two or more indicators:
|
Age | WEIGHT GAIN a | |
---|---|---|
Boys | Girls | |
0–1 month | 27–41 g/day | 23–36 g/day |
1–2 months | 33–47 g/day | 28–40 g/day |
2–3 months | 22–33 g/day | 19–29 g/day |
3–4 months | 16–26 g/day | 15–24 g/day |
4–5 months | 13–22 g/day | 12–21 g/day |
5–6 months | 10–19 g/day | 9–18 g/day |
6–7 months | 7–17 g/day | 7–16 g/day |
7–8 months | 6–15 g/day | 6–15 g/day |
8–9 months | 5–14 g/day | 5–14 g/day |
9–10 months | 4–14 g/day | 4–13 g/day |
10–12 months | 3–13 g/day | 3–13 g/day |
12–24 months | 5–10 g/day | |
2–10 years | 2–3 kg/year |
a Based on World Health Organization standards between 25th and 75th percentiles.
Age | Length/Height | Head Circumference |
---|---|---|
Premature <2 kg | 0.8–1.1 cm/wk | 0.8–1 cm/wk |
Premature ≥2 kg | 0.8–1.1 cm/wk | 0.8–1 cm/wk |
0–4 months | 0.8–0.93 cm/wk | 0.38–0.48 cm/wk |
4–8 months | 0.37–0.47 cm/wk | 0.16–0.2 cm/wk |
8–12 months | 0.28–0.37 cm/wk | 0.08–0.11 cm/wk |
12–16 months | 0.24–0.33 cm/wk | 0.04–0.08 cm/wk |
16–20 months | 0.21–0.29 cm/wk | 0.03–0.06 cm/wk |
20–24 months | 0.19–0.26 cm/wk | 0.02–0.04 cm/wk |
2–10 years | 5–8 cm/y | N/A |
Age | Recommended Dietary Allowance | Energy Required for Catch-up Growth (kcal/kg per day) | Protein (g/kg per day) |
---|---|---|---|
0–6 months | 108 | 120–150+ | 2.2–3.5 |
7 months to 1 year | 98 | 110–140 | 1.5–2.5 |
1–3 years | 102 | 100–120 | 1.2–2.0 |
4–6 years | 90 | 80–100 | 1.2–1.5 |
7–10 years | 70 | 60–90 | 1.2–1.5 |
11–14 years | |||
Male | 55 | 55–60 | 1.0–1.5 |
Female | 45 | 45–60 | 1.0–1.5 |
15–18 years | |||
Male | 47 | 45–55 | 1.0–1.5 |
Female | 40 | 45–55 | 1.0–1.5 |
Weight (kg) | Fluid |
---|---|
1–10 kg | 100 mL/kg per day |
11–20 kg | 1000 mL + 50 mL/kg for each kg >10 kg |
>20 kg | 1500 mL + 20 mL/kg for each kg >20 kg |
Formula | Type | MCT:LCT Ratio | Percent Calories From LCT Fat | LCT Fat g/100 Calories |
---|---|---|---|---|
Enfaport a (Mead Johnson) | Liquid concentrate 30 calories/ounce | 83:17 | 7.8 | 0.9 |
Lipistart a (Néstle) | Powder | 80:20 | 7.6 | 0.82 |
Monogen a (Nutricia) | Powder | 83:17 | 4.5 | 0.5 |
Portagen a,b (Mead Johnson) | Powder | 87:13 | 5.5 | 0.6 |
Tolerex c (Néstle) | Powder | 0:100 | 2 | 0.2 |
Vivonex Pediatric c (Néstle) | Powder | 70:30 | 7.5 | 0.87 |
Vivonex TEN c (Néstle) | Powder | 0:100 | 3 | 0.3 |